• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    N

    National Cancer Center Hospital East

    EST. 1962
    7,736论文总数
    19.6万引用总数

    论文量&引用量时间轴

    机构学者

    排序
    Takayuki Yoshino
    Takayuki Yoshino
    National Cancer Center Hospital East
    论文:669引用:0H-index:0
    Koichi Goto
    Koichi Goto
    Department of Thoracic Oncology, National Cancer Center Hospital East
    论文:499引用:0H-index:0
    Kohei Shitara
    Kohei Shitara
    Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East
    论文:499引用:0H-index:0
    Atsushi Ohtsu
    Atsushi Ohtsu
    Gastrointestinal Oncology Department, National Cancer Center Hospital East
    论文:402引用:0H-index:0
    Tujing junyan
    Tujing junyan
    Department of Gastrointestinal Oncology, National Cancer Center Hospital East
    论文:395引用:0H-index:0
    Masafumi Ikeda
    Masafumi Ikeda
    Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East;Yokohama National University
    论文:386引用:0H-index:0
    Makoto Tahara
    Makoto Tahara
    Division of Head and Neck Medical Oncology, National Cancer Center Hospital East
    论文:321引用:0H-index:0
    Kiyotaka Yoh
    Kiyotaka Yoh
    National Cancer Center Hospital East
    论文:293引用:0H-index:0
    Masahiro Tsuboi
    Masahiro Tsuboi
    Department of Thoracic Surgery and Oncology, National Cancer Center Hospital East
    论文:287引用:0H-index:0

    论文(7735)

    年份
    起
    –
    止
    排序
    1Correction: Epidemiology and Real-World Outcomes in Patients with Human Epidermal Growth Factor Receptor 2 (Her2)-Mutant Non-small Cell Lung Cancer by Region: A Targeted Literature Review
    Koichi Goto,Hidetoshi Hayashi,Sonia S. Maruti, Heiko Zettl, Lalith Mittal, Smit Pathak,Xiuning Le

    Human epidermal growth factor receptor 2 (HER2) mutations in non-small cell lung cancer (NSCLC) are associated with aggressive disease and poor prognosis. Improved understanding of patient characteristics is vital to advance personalized treatment and improve outcomes. In this structured protocol-based targeted literature review, we assessed the epidemiology and ‘real-world’ outcomes in patients with HER2-mutant NSCLC by region, and by mutation category (tyrosine kinase domain [TKD] and non-TKD). Across 64 studies, the frequency of HER2 mutations ranged from 1

    2026Targeted Oncology(2026)引用:94
    引用
    AI阅读
    加入学术空间
    2Diagnostic Performance of Magnifying Endoscopy with Third-Generation Narrow-Band Imaging for Early Gastric Cancer: Post Hoc Analysis of a Randomized Trial (3G Detection Trial)
    Nobuhisa Minakata,Tomohiro Kadota,Seiichiro Abe,Noriya Uedo,Hisashi Doyama,Yasuaki Furue,Akira Yokoyama,Satoru Nonaka, Yasuhiro Tani,Naohiro Yoshida,Chikatoshi Katada,Manabu Muto,

    In this study, we investigated the diagnostic performance of magnifying endoscopy (ME) with third-generation narrow-band imaging (3G-NBI) for early gastric cancer (EGC), primarily in patients with Helicobacter pylori eradication. This was a post hoc analysis of a multicenter, randomized trial comparing 3G-NBI, texture and color enhancement imaging, and white-light imaging in gastric neoplasm (GN) detection. For all detected lesions, the endoscopic diagnosis of ME using 3G-NBI was compared with the pathological diagnosis. The primary analyses focused on the sensitivity and specificity of ME with 3G-NBI for EGC or non-EGC. The diagnostic performance was analyzed according to confidence level, macroscopic type, lesion size, and H. pylori infection status. This study included 901 patients; 228 suspected GN lesions in 187 patients were analyzed. The lesions were diagnosed with EGC in 62 (27 with high confidence) and non-EGC in 166 (91 with high confidence) patients using ME with 3G-NBI and pathologically diagnosed as EGC in 61 and non-EGC in 167 patients. The overall diagnostic performance was sensitivity and specificity of 70.5

    2026Journal of Gastroenterology(2026)引用:29
    引用
    AI阅读
    加入学术空间
    3Optimal Preoperative Bowel Preparation for Intracorporeal Anastomosis in Laparoscopic Colectomy
    Shoma Sasaki,Daichi Kitaguchi,Masaaki Ito, Keitaro Tanaka,Tomohiro Yamaguchi,Jun Watanabe,Hiroki Hamamoto,Atsushi Nishimura,Fumihiko Fujita,Ryo Inada,Hiroki Takahashi,Masashi Miguchi,

    There are concerns regarding postoperative infections following laparoscopic colectomy with intracorporeal anastomosis. Thus, in this study, we aimed to determine the optimal preoperative bowel preparation to reduce postoperative infectious complications in patients undergoing laparoscopic colectomy with intracorporeal anastomosis. This secondary analysis of the ICAN study—a multicenter, retrospective cohort study involving 46 institutions affiliated with the Japan Society of Laparoscopic Colorectal Surgery—included 615 patients with colon adenocarcinoma undergoing laparoscopic colectomy with intracorporeal anastomosis between January 2020 and December 2021. Patients were analyzed after applying eligibility criteria and propensity score matching based on age ≥ 65 years, sex, body mass index ≥ 30, American Society of Anesthesiologists Physical Status, diabetes, and the number of intracorporeal anastomosis cases previously performed at the institution. Among them, 312 received combined oral antibiotics and mechanical bowel preparation, whereas 156 received other preparations (mechanical preparation alone, oral antibiotics alone, and no preparation). The primary outcome was surgical wound infection incidence (Clavien–Dindo grade ≥ II) at initial discharge. Secondary outcomes included intraperitoneal infections, anastomotic leakage, ileus, and postoperative hospital stay. Surgical wound infection (1/312 [0.3

    2026Surgical Endoscopy(2026)引用:25
    引用
    AI阅读
    加入学术空间
    4Nationwide Quality Indicator Survey on the Current Practice of Esophageal Cancer Management in Japan: Report from the Guideline Committee for the 6th Edition of the Japanese Esophageal Cancer Practice Guidelines.
    Eisuke Booka,Hiroya Takeuchi,Ryu Ishihara,Katsunori Iijima,Hitoshi Ishikawa,Yoshinori Ito,Takashi Oyama,Ken Kato,Hirofumi Kawakubo, Hiroshi Kawachi, Yasue Kimura,Shiko Kuribayashi,

    BACKGROUND:To evaluate the dissemination and real-world implementation of recommendations from the 5th Edition of the Japanese Esophageal Cancer Practice Guidelines and to inform development of the upcoming 6th Edition, the Guideline Committee of the Japanese Esophageal Society conducted a nationwide Quality Indicator (QI) survey in Japan. METHODS:A nationwide, cross-sectional, web-based questionnaire survey was distributed to 381 certified institutions participating in the 2023 National Registry of Esophageal Cancer in Japan. Conducted in November 2024, the survey covered six domains-epidemiology, surgery, endoscopy, chemotherapy, radiation therapy, and pathology-reflecting key recommendations of the 5th Edition. Responses were summarized descriptively at the institutional level. RESULTS:Valid responses were obtained from 190 institutions (49.9%). Smoking cessation guidance was implemented in more than 90% of institutions, and over 90% also provided guidance on alcohol abstinence or moderation, although complete alcohol abstinence was less uniformly recommended. Minimally invasive, including robot-assisted, esophagectomy was adopted by over 90% of institutions. The proportion of institutions performing prophylactic cervical lymph node dissection varied by tumor location and stage, reflecting contemporary staging concepts. The DCF regimen was the predominant neoadjuvant therapy for stage II/III disease (94.7%), and immune checkpoint inhibitor-based chemotherapy was widely used for unresectable or recurrent disease. Advanced endoscopic diagnostic modalities, including magnifying and image-enhanced endoscopy, were widely adopted. CONCLUSIONS:This nationwide QI survey demonstrates broad adherence to guideline-based multidisciplinary management of esophageal cancer in Japan and provides an evidence base for refining recommendations in the 6th Edition of the Japanese Esophageal Cancer Practice Guidelines.

    2026Esophagus(2026)引用:24
    引用
    AI阅读
    加入学术空间
    5Standardization of Surgical Gesture Taxonomy: a SAGES Delphi Consensus Study
    Maria Clara Morais, Aditya Amit Godbole, Emaad Iqbal, Mattia Ballo,Anthony Jarc, Beatrice Van Amsterdam, Brent Matthews,Christopher M. Schlachta, Daniel A. Donoho,Daniel A. Hashimoto, Jay A. Redan, Jayson Marwaha,

    Artificial intelligence (AI) for surgical workflow analysis often fails to generalize because surgical actions lack a standardized, fine-grained representation. Gesture-level “tokenization” of surgery, capturing instrument–tissue interactions as the smallest intentional functional units, offers greater technical specificity than phase- or step-level labels and has demonstrated associations with proficiency and clinical outcomes. However, the field remains fragmented by heterogeneous gesture terminology, limiting dataset interoperability and model reproducibility. We conducted a SAGES-led, accelerated Delphi consensus process to establish a standardized surgical gesture taxonomy. Starting with 270 literature-derived gesture terms, we employed a novel hybrid pipeline combining large language model (LLM)-assisted semantic clustering with multi-round expert review. The process involved two Delphi surveys (open-ended, then structured agreement) with a predefined ≥ 80

    2026Surgical Endoscopy(2026)引用:18
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 7735 篇论文

    合作机构(100)

    新潟癌症中心医院合作论文 853
    静冈癌症中心合作论文 539
    东京大学合作论文 461
    九州大学合作论文 407
    Aichi Cancer Center合作论文 406
    Hokkaido University Hospital合作论文 398
    近畿大学合作论文 386
    京都大学合作论文 384
    国家癌症中心合作论文 368
    Kanagawa Cancer Center合作论文 334

    机构统计